Capvizr
News · All summaries
Healthcare & Life Sciences
Sanyou Biopharmaceuticals
Series CUndisclosed
RoundSeries C
AmountUndisclosed
LeadZero2IPO Industry Investment
HQShanghai, China
DateNovember 9, 2026
THE DEAL, AT A GLANCE

Sanyou Biopharmaceuticals

From the announcement
Who is involvedBacked by Zero2IPO Industry InvestmentFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
What happenedSanyou Biopharmaceuticals raised Series C, announced 2026-11-09From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Why it mattersSanyou Biopharmaceuticals' Series C indicates continued investor participation in a biopharmaceutical company, although the recorded round size conflicts with the…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Sanyou Biopharmaceuticals · Financing Record

Explore source-linked visual explanations for Sanyou Biopharmaceuticals. Unsupported claims are withheld while source review continues.

Record 15967 · Recorded date: 2026-11-09

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime